EGFR and non-small cell lung carcinoma: Overexpression of EGFR is associated with resistance to chemotherapy and radiotherapy and poor prognosis in many cancers, such as head and neck squamous cell carcinoma (HNSCC) [3], breast cancer [4], and non-small-cell lung cancer (NSCLC) [5].